Salix confirms US FDA rejection of Xifaxan for IBS
08 March 2011
Donna Young
Please Login to read the full article.
08 March 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Hope not enough for Avastin in MBC; Hamburg explains withdrawal
- Salix presents data to expand markets for bowel disorder drugs Xifaxan and Relistor
- Salix bumps up GI portfolio with Oceana buy for $300m
- Salix issues $600 million in cheap new convertible debt
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
